http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Sung, S.x2010,H.,Park, S.x2010,H.,Song, S.x2010,Y.,Lee, S.x2010,J.,Lee, H.x2010,W.,Kim, S.x2010,H.,A Lee, M.,Yoon, I.x2010,S.,Kim, D.x2010,D.,Kang, S.,Sung, J.x2010,H. Blackwell Publishing Ltd 2011 Cell proliferation Vol.44 No.6
<P><B>Abstract</B></P><P><B>Objectives: </B> Keratinocyte stem/progenitor cells (KSCs) are known to regenerate epidermal tissue which they perform through to their great regenerative capacity.</P><P><B>Materials and methods: </B> Because stimulation of resident KSCs may regenerate epidermal tissue, we devised a strategy to find an appropriate KSC activator from natural products and to develop it as a skin‐rejuvenating agent.</P><P><B>Results: </B> <I>Ent</I>‐16α, 17‐dihydroxy‐kauran‐19‐oic acid (DHK) isolated from <I>Siegesbeckia pubescens</I> exhibited a KSC‐stimulating effect during screening of natural products. DHK increased proliferation and migration of KSCs using the Akt/ERK pathway. We further examined the mechanism of KSC stimulation and found that phosphorylation of Y1068 epithelial growth factor receptor (EGFR) was significantly increased. Functional inhibition of EGFR using neutralizing antibody and a chemical inhibitor, AG1478, attenuated DHK‐induced KSC stimulation. In a 3D culture model of KSCs, DHK treatment significantly induced establishment of fully stratified epidermis and increased numbers of p63‐positive cells. Likewise, DHK treatment significantly accelerated healing of epidermal wounds created by laser and dermatome, and increased p63‐positive cells, in animal models.</P><P><B>Conclusion: </B> Collectively, these results indicate that DHK regenerates epidermal tissue mainly through EGFR phosphorylation. As DHK has diverse advantages over recombinant growth factors for commercialization (that is long‐term stability and skin permeability), DHK might be applied to wound‐healing agents and to a basic materials used in cosmetics.</P>
Yu, Kx2010,H.,Hong, Kx2010,S.,Lee, Bx2010,C.,Oh, Mx2010,S.,Cho, Yx2010,J.,Koo, Jx2010,S.,Park, Jx2010,M.,Bae, Hx2010,J.,Han, Mx2010,K.,Ju, Yx2010,S.,Kang, Dx2010,W.,Appelros, P. Blackwell Publishing Ltd 2011 Acta neurologica Scandinavica Vol.123 No.5
<P>Yu K‐H, Hong K‐S, Lee B‐C, Oh M‐S, Cho Y‐J, Koo J‐S, Park J‐M, Bae H‐J, Han M‐K, Ju Y‐S, Kang D‐W, Appelros P, Norrving B, Terent A. Comparison of 90‐day case‐fatality after ischemic stroke between two different stroke outcome registries using propensity score matching analysis. Acta Neurol Scand: 2011: 123: 325–331. © 2010 John Wiley & Sons A/S.</P><P><B>Background – </B> It has not been clarified whether the disparity in ischemic stroke outcome between populations is caused by ethnic and geographic differences or by variations in case mix. Propensity score matching (PSM) analysis can overcome some analytical problems but is rarely used in stroke outcome research. This study was to compare the ischemic stroke case‐fatality between two PSM cohorts of Sweden and Korea.</P><P><B>Methods – </B> Prognostic variables related to baseline characteristics and stroke care were included in our PSM model. Then, we selected 7675 Swedish and 1220 Korean patients with ischemic stroke from each stroke registers and performed one‐to‐one matching based on propensity scores of each patient.</P><P><B>Results – </B> After PSM, all measured variables were well balanced in 1163 matched subjects, and the 90‐day case‐fatality was identical 6.2% (HR 0.997, 95%CI 0.905–1.099) in Sweden and Korea.</P><P><B>Conclusions – </B> No difference is found in the 90‐day case‐fatality in propensity score‐matched Swedish and Korean patients with ischemic stroke.</P>
Yoon, Kuk Ro,Ramaraj, B.,Lee, Seungho,Yu, Jongx2010,Sung,Choi, Insung S. Wiley Subscription Services, Inc., A Wiley Company 2009 Journal of biomedical materials research. Part A Vol.a88 No.3
<P><B>Abstract</B></P><P>A sugar‐containing polymer was grown on gold surface by surface‐initiated atom‐transfer radical polymerization (SI‐ATRP) of methacrylate monomer, 3‐<I>O</I>‐methacryloyl‐1,2:5,6‐di‐<I>O</I>‐isopropylidene‐α‐<SMALL>D</SMALL>‐glucofuranoside (MAIpGIc), using 1,4,8,11‐tetraaza‐1,4,8,11‐tetramethylcyclotetradecane (Me<SUB>4</SUB>Cyclam) as ligand, 2‐bromopropionyl moiety attached on the gold surface as initiator, and Copper(I) bromide as catalyst, respectively, in tetrahydrofuran (THF) medium. The resultant sugar film was characterized by polarized infrared external reflectance spectroscopy (PIERS), X‐ray photoelectron spectroscopy (XPS), atomic force microscopy (AFM), field emission scanning electron microscopy (FE‐SEM), ellipsometry, and contact angle goniometry. The IR peaks characteristics of poly(3‐<I>O</I>‐methacryloyl‐α,β‐<SMALL>D</SMALL>‐glucopyranoside) (PMAGlc), broad OH stretch at ∼3400 cm<SUP>−1</SUP>, and CO ester stretch at ∼1748 cm<SUP>−1</SUP> observed in PIERS spectra demonstrate the formation of PMAGlc on the gold surface. The AFM and SEM images show the polymer growth away from the gold surface without visible domain boundaries, and it further confirms the formation of sugar coating. The method described in the article would be beneficial in many areas, such as pathogen detection and biosensors, considering the biological importance of carbohydrate polymers. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009</P>
Plant‐expressed Fc‐fusion protein tetravalent dengue vaccine with inherent adjuvant properties
Kim, Mi Young,Copland, Alastair,Nayak, Kaustuv,Chandele, Anmol,Ahmed, Muhammad S.,Zhang, Qibo,Diogo, Gil R.,Paul, Matthew J.,Hofmann, Sven,Yang, Moonx2010,Sik,Jang, Yongx2010,Suk,Ma, Julian Kx20 BLACKWELL 2018 PLANT BIOTECHNOLOGY JOURNAL Vol.16 No.7
<P><B>Summary</B></P><P>Dengue is a major global disease requiring improved treatment and prevention strategies. The recently licensed Sanofi Pasteur Dengvaxia vaccine does not protect children under the age of nine, and additional vaccine strategies are thus needed to halt this expanding global epidemic. Here, we employed a molecular engineering approach and plant expression to produce a humanized and highly immunogenic poly‐immunoglobulin G scaffold (PIGS) fused to the consensus dengue envelope protein III domain (cEDIII). The immunogenicity of this IgG Fc receptor‐targeted vaccine candidate was demonstrated in transgenic mice expressing human FcγRI/CD64, by induction of neutralizing antibodies and evidence of cell‐mediated immunity. Furthermore, these molecules were able to prime immune cells from human adenoid/tonsillar tissue <I>ex vivo</I> as evidenced by antigen‐specific CD4<SUP>+</SUP> and CD8<SUP>+</SUP> T‐cell proliferation, IFN‐γ and antibody production. The purified polymeric fraction of dengue PIGS (D‐PIGS) induced stronger immune activation than the monomeric form, suggesting a more efficient interaction with the low‐affinity Fcγ receptors on antigen‐presenting cells. These results show that the plant‐expressed D‐PIGS have the potential for translation towards a safe and easily scalable single antigen‐based tetravalent dengue vaccine.</P>
Cho, K.x2010,C.,Han, Y.x2010,J.,Kim, S.x2010,J.,Lee, S.x2010,S.,Hwang, O.x2010,J.,Song, P.x2010,S.,Kim, Y.x2010,S.,Kim, J.x2010,I. Blackwell Publishing Ltd 2011 Plant pathology Vol.60 No.4
<P>A pepper esterase (<I>PepEST</I>) gene was introduced into creeping bentgrass (<I>Agrostis stolonifera</I>) by <I>Agrobacterium</I>‐mediated transformation. Purified recombinant PepEST proteins were sufficient to inhibit the growth of the fungal pathogens <I>Rhizoctonia solani</I> AG2‐2 (IIIB) (causing brown patch) and <I>Sclerotinia homoeocarpa</I> (dollar spot), but not the oomycete responsible for pythium blight, <I>Pythium aphanidermatum</I>. PepEST proteins were most effective against <I>R.?solani</I>. After genetic transformation of creeping bentgrass with <I>PepEST</I>, the genomic integration of transgenes <I>bar</I> and <I>PepEST</I> was confirmed by Southern blot analysis, and their expression was also validated by northern blot and western blot analyses. Disease severity on <I>R.?solani</I>‐inoculated leaves of transgenic plants was <10% compared to <I>ca</I>. 50% in non‐transgenic plants. Microscopic observation of infected leaves indicated that PepEST inhibited the growth of hyphae upon fungal infection.</P>
Lee, Chongx2010,Yong,Park, Hyun S.,Fontecillax2010,Camps, Juan C.,Reisner, Erwin John Wiley and Sons Inc. 2016 Angewandte Chemie Vol.55 No.20
<P><B>Abstract</B></P><P>The combination of enzymes with semiconductors enables the photoelectrochemical characterization of electron‐transfer processes at highly active and well‐defined catalytic sites on a light‐harvesting electrode surface. Herein, we report the integration of a hydrogenase on a TiO<SUB>2</SUB>‐coated p‐Si photocathode for the photo‐reduction of protons to H<SUB>2</SUB>. The immobilized hydrogenase exhibits activity on Si attributable to a bifunctional TiO<SUB>2</SUB> layer, which protects the Si electrode from oxidation and acts as a biocompatible support layer for the productive adsorption of the enzyme. The p‐Si|TiO<SUB>2</SUB>|hydrogenase photocathode displays visible‐light driven production of H<SUB>2</SUB> at an energy‐storing, positive electrochemical potential and an essentially quantitative faradaic efficiency. We have thus established a widely applicable platform to wire redox enzymes in an active configuration on a p‐type semiconductor photocathode through the engineering of the enzyme–materials interface.</P>
Serum Concentrations of Leptin and Adiponectin in Dogs with Myxomatous Mitral Valve Disease
Kim, H.x2010,S.,Kang, J.x2010,H.,Jeung, E.x2010,B.,Yang, M.x2010,P. John Wiley and Sons Inc. 2016 Journal of veterinary internal medicine Vol.30 No.5
<P><B>Background</B></P><P>The concentrations of circulating adipokines in dogs with myxomatous mitral valve disease (MMVD) have not been investigated in detail.</P><P><B>Objectives</B></P><P>To determine whether serum concentrations of adipokines differ between healthy dogs and dogs with MMVD and whether circulating concentrations depend on the severity of heart failure resulting from MMVD.</P><P><B>Animals</B></P><P>In the preliminary study, 30 healthy dogs and 17 client‐owned dogs with MMVD, and in the subsequent study, 30 healthy dogs and 46 client‐owned dogs with MMVD.</P><P><B>Methods</B></P><P>Prospective case‐controlled observational study. In the preliminary study, serum concentrations of leptin, adiponectin, resistin, visfatin, interleukin (IL)‐1β, IL‐6, IL‐10, IL‐18, and tumor necrosis factor‐α were measured. In the subsequent study, MMVD dogs were divided into three groups according to the International Small Animal Cardiac Health Council (ISACHC) classification, and serum concentrations of leptin and adiponectin were measured.</P><P><B>Results</B></P><P>In the preliminary study, serum leptin and adiponectin concentrations differed significantly between dogs with MMVD and healthy dogs. Serum leptin (<I>P</I> = .0013) concentrations were significantly higher in dogs with MMVD than in healthy dogs, whereas adiponectin (<I>P</I> = .0009) concentrations were significantly lower in dogs with MMVD. However, we observed no significant differences in the other variables. In the subsequent study, dogs classified as ISACHC class 3 had higher serum concentrations of leptin (<I>P</I> = .0022) than healthy dogs but ISACHC class 1 or 2 dogs did not. Serum adiponectin concentrations were significantly lower in ISACHC class 1 (<I>P</I> < .0001) dogs than in healthy dogs, whereas adiponectin concentrations in ISACHC class 3 dogs were significantly higher than in ISACHC class 1 dogs (<I>P</I> = .0081).</P><P><B>Conclusions and Clinical Importance</B></P><P>Circulating concentrations of leptin and adiponectin might be altered in dogs with MMVD.</P>
Zhao, W.x2010,G.,Chung, J.x2010,W.,Lee, G.x2010,A.,Ma, K.x2010,H.,Kim, H.x2010,H.,Kim, K.x2010,T.,Chung, I.x2010,M.,Lee, J.x2010,K.,Kim, N.x2010,S.,Kim, S.x2010,M.,Park, Y.x2010 Blackwell Publishing Ltd 2011 Plant breeding Vol.130 No.1
<P> <I>With 7 figures and 6 tables</I> </P><P><B>Abstract</B></P><P>Garlic is widely consumed for its culinary and medical benefits. Six hundred and thirteen accessions of garlic and its relatives with diverse origin were evaluated for genetic diversity at eight recently novel simple sequence repeat loci in this study. A total of 113 alleles were detected, the average allelic richness was 14.1 alleles per locus. Using a heuristic approach, a core set of 95 accessions was successfully developed, which showed 100% coverage of alleles with minimum redundancy. The model‐based structure analysis here revealed the presence of four subpopulations in the selected core set, which was basically consistent with clustering based on the genetic distance. The analysis of molecular variance based on this core set showed that between‐population component of genetic variance is <15.6% in contrast to 84.4% for the within population component. Overall <I>F</I><SUB>ST</SUB> value was 0.1560, indicating a moderate differentiation among the four groups. These results will provide an effective aid for future allele mining, association genetics, mapping and cloning gene(s), germplasm conservation, and improvement programs.</P>
Song, Dx2010,S.,Park, Jx2010,C.,Jung, Ix2010,H.,Choi, S‐,H.,Cho, Kx2010,S.,Kim, Cx2010,K.,Kim, Cx2010,S. Blackwell Publishing Ltd 2011 Journal of periodontal research Vol.46 No.2
<P> <I>Song D‐S, Park J‐C, Jung I‐H, Choi S‐H, Cho K‐S, Kim C‐K, Kim C‐S. Enhanced adipogenic differentiation and reduced collagen synthesis induced by human periodontal ligament stem cells might underlie the negative effect of recombinant human bone morphogenetic protein‐2 on periodontal regeneration. J Periodont Res 2011; 46: 193–203. © 2010 John Wiley & Sons A/S</I> </P><P><B>Background and Objective: </B> Recombinant human bone morphogenetic protein‐2 (rhBMP‐2) is a potent inducer for the regeneration of mineralized tissue, but has a limited effect on the regeneration of cementum and periodontal ligament (PDL). The aim of the present study was to determine the effects of rhBMP‐2 on the <I>in vitro</I> and <I>in vivo</I> biologic activity of well‐characterized human PDL stem cells (hPDLSCs) and to elucidate the underlying mechanism of minimal periodontal regeneration by rhBMP‐2.</P><P><B>Material and Methods: </B> hPDLSCs were isolated and cultured, and then transplanted into an ectopic subcutaneous mouse model using a carrier treated either with or without rhBMP‐2. Comprehensive histologic, histometric and immunohistochemical analyses were performed after an 8‐wk healing period. The effects of rhBMP‐2 on the adipogenic and osteogenic/cementogenic differentiation of hPDLSCs were also evaluated. The effect of rhBMP‐2 on both soluble and insoluble collagen synthesis was analyzed, and the expression of mRNA and protein for collagen types I, II, III and V was assessed.</P><P><B>Results: </B> In the present study, rhBMP‐2 promoted both adipogenic and osteogenic/cementogenic differentiation of hPDLSCs <I>in vitro</I>, and the <I>in vivo</I> potential of hPDLSCs to form mineralized cementum and organized PDL tissue was down‐regulated following treatment with rhBMP‐2. Collagen synthesis, which plays a crucial role in the regeneration of cementum and the periodontal attachment, was significantly reduced, with associated modification of the relevant mRNA and protein expression profiles.</P><P><B>Conclusion: </B> In summary, the findings of the present study suggest that enhanced adipogenic differentiation and inhibition of collagen synthesis by hPDLSCs appear to be partly responsible for the minimal effect of rhBMP‐2 on cementum and PDL tissue regeneration by hPDLSCs.</P>
Park, Jx2010,C.,So, S‐,S.,Jung, Ix2010,H.,Yun, Jx2010,H.,Choi, S‐,H.,Cho, Kx2010,S.,Kim, Cx2010,S. Blackwell Publishing Ltd 2011 Journal of periodontal research Vol.46 No.6
<P><I>Park J‐C, So S‐S, Jung I‐H, Yun J‐H, Choi S‐H, Cho K‐S, Kim C‐S. Induction of bone formation by</I> Escherichia coli<I>‐expressed recombinant human bone morphogenetic protein‐2 using block‐type macroporous biphasic calcium phosphate in orthotopic and ectopic rat models. J Periodont Res 2011; 46: 682–690. © 2011 John Wiley & Sons A/S</I></P><P><B>Background and Objective: </B> The potential of the <I>Escherichia coli</I>‐expressed recombinant human bone morphogenetic protein‐2 (ErhBMP‐2) to support new bone formation/maturation using a block‐type of macroporous biphasic calcium phosphate (bMBCP) carrier was evaluated in an orthotopic and ectopic rat model.</P><P><B>Material and Methods: </B> Critical‐size (Φ 8 mm) calvarial defects and subcutaneous pockets in 32 Sprague–Dawley rats received implants of rhBMP‐2 (2.5 μg) in a bMBCP carrier or bMBCP alone (control). Implant sites were evaluated using histological and histometric analysis following 2‐ and 8‐wk healing intervals (eight animals/group/interval).</P><P><B>Results: </B> ErhBMP‐2/bMBCP supported significantly greater bone formation at 2 and 8 wk (10.8% and 25.4%, respectively) than the control at 2 and 8 wk (5.3% and 14.0%, respectively) in calvarial defects (<I>p</I> < 0.01). Bone formation was only observed for the ErhBMP‐2/bMBCP ectopic sites and was significantly greater at 8 wk (7.5%) than at 2 wk (4.5%) (<I>p</I> < 0.01). Appositional and endochondral bone formation was usually associated with a significant increase in fatty marrow at 8 wk. The bMBCP carrier showed no evidence of bioresorption.</P><P><B>Conclusion: </B> ErhBMP‐2/bMBCP induced significant bone formation in both calvarial and ectopic sites. Further study appears to be required to evaluate the relevance of the bMBCP carrier.</P>